http://ec.europa.eu/research/brainmonth2013 Within the Month of the Brain, two major conferences are planned for 14 May (Brussels, Belgium) and 27&28 May (Dublin, Ireland). 14 May 2013 (Brussels, Belgium): This first conference will be dedicated to “European Brain Research: Successes and Next… Continue Reading

EBC – External Environment Reports and EU Research updates As you are aware, times change so quickly that we must think, work, step out of the box we are in. In order to help to better understand the environment in… Continue Reading

Abstract Objective: Idiopathic REM sleep behavior disorder (RBD) is a potential preclinical marker for the development of neurodegenerative diseases, particularly Parkinson disease (PD) and Lewy body dementia. However, the long-term risk of developing neurodegeneration in patients with idiopathic RBD has… Continue Reading

Professor Babro Westerholm is a Swedish Liberal People's Party politician. She has been a member of the Riksdag since 2006. She was previously a member from 1988 to 1999. From the mid 1960s Westerholm was an early pioneer in the field of pharmacovigilance, also working on the early stages of the WHO Drug Dictionary and the WHO Programme for International Drug Monitoring.

by Sara Machado et al. Introduction: Neuromyelitis optica (NMO) affects preferentially the optic nerve and spinal cord; and its serum marker, the antibody against AQP4, has improved the diagnosis. AQP4 is heavily expressed in area postrema, which explains clinical presentations… Continue Reading

Neuropenews is an open internet bulletin and it seems we are read not only by neurologists and neuroscientists but also by the lay public. We have namely obtained the occasional letter from a neurological patient.
As neurologists we appreciate the… Continue Reading

One of the special sessions at the EFNS Congress in Stockholm was devoted to ‘Critical illness and end-of-life considerations’, and held on 11 September 2012. The session was announced in the Programme book: There is an interface between law and… Continue Reading

by Gustave Moonen and Jacques de Reuck EFNS and ENS are very pleased to announce their upcoming Joint Congress in 2014: The congress will take place at the Istanbul Congress Centre and start on Saturday May 31 and end on… Continue Reading

The Editors have – together with the Scientific Committee – decided that new guideline papers will be presented in the Forum of NEUROPENEWS. In the December 2012 issue of the European Journal of Neurology the new guideline paper on the… Continue Reading

by Gian Luigi Lenzi With this December issue, NEUROPENEWS has published 12 issues in 2012: one year of presence in the Neuroweb panorama and for the EFNS web-linked fellows. So, it is the right time for a summary and self-examination.… Continue Reading

Sherlock Holmes lived round the corner from my home at the fictitious address of 221b Baker Street. His larger than life statue nurses his traditional pipe as he greets travellers emerging from Baker Street underground station. For him evidence might be as little as a trace of mud on the soles of a suspect’s shoes. For neurologists observation may be adequate evidence for a clinical diagnosis and observational evidence may even suffice for some treatments.

Immunological features of late-onset myasthenia (LOMG) in comparison to early-onset myasthenia (EOMG).

All e-learning activities are free-of-charge for EFNS members registered to www.efns.org! Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology
Every month one article is chosen for online learning. The following articles are… Continue Reading

The 5th European Board Examination will be held on Friday June 7, 2013 in conjunction with the 23rd Meeting of the European Neurological Society in Barcelona, Spain. Until 2012 the EBN Examination has been restricted to countries of the EU… Continue Reading

Abstract
We report the results of a meta-analysis of genome-wide association scans for multiple sclerosis (MS) susceptibility that includes 2,624 subjects with MS and 7,220 control subjects. Replication in an independent set of 2,215 subjects with MS and 2,116 control… Continue Reading